1. Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin and isoniazid resistance detection
    Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin and isoniazid resistance detection
    Tuberculosis (TB)
    Setting
    Laboratory
  2. Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin resistance detection
    Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin resistance detection
    HIV infection, Meningitis, Tuberculosis (TB)
    Setting
    Laboratory
  3. Culture-based drug susceptibility testing of antituberculosis drugs
    Solid medium (Löwenstein–Jensen medium, Middlebrook 7H10 or 7H11 agar media)
    Culture-based drug susceptibility testing (DST) of antituberculosis drugs
    Tuberculosis (TB)
    Setting
    Laboratory
    Assay format
  4. Culture-based drug susceptibility testing of antituberculosis drugs
    Liquid medium
    Culture-based drug susceptibility testing (DST) of antituberculosis drugs
    Tuberculosis (TB)
    Setting
    Laboratory
    Assay format
  5. Interferon-gamma release assay
    Interferon-gamma release assay (IGRA)
    Tuberculosis (TB)
    Setting
    Laboratory
  6. Lipoarabinomannan antigen
    Lipoarabinomannan (LAM) antigen
    HIV infection, Tuberculosis (TB)
    Setting
    Non-laboratory
    Assay format
  7. Mycobacterial culture
    Solid medium (Löwenstein–Jensen medium, Middlebrook 7H10 or 7H11 agar media). WHO recommended in 2025 WRDs (molecular techniques)
    Mycobacterial culture
    Tuberculosis (TB)
    Setting
    Laboratory
    Assay format
  8. Mycobacterial culture
    Liquid medium
    Mycobacterial culture
    Tuberculosis (TB)
    Setting
    Laboratory
    Assay format
  9. Mycobacterium tuberculosis nucleic acid amplification test
    Mycobacterium tuberculosis nucleic acid amplification test
    HIV infection, Tuberculosis (TB)
    Setting
    Laboratory
  10. Nucleic acid amplification test for detection of TB drugs resistance
    Nucleic acid amplification test for detection of TB drug resistance
    Tuberculosis (TB)
    Setting
    Laboratory
  11. Nucleic acid amplification test for detection of TB drugs resistance
    First-line drug LPAs and second-line drug LPAs
    Nucleic acid amplification test for detection of TB drug resistance
    Tuberculosis (TB)
    Setting
    Laboratory
  12. Nucleic acid amplification test for pyrazinamide resistance detection
    Nucleic acid amplification test for pyrazinamide resistance detection
    Tuberculosis (TB)
    Setting
    Laboratory
  13. Nucleic acid amplification test for rifampicin and isoniazid resistance detection
    Nucleic acid amplification test for rifampicin and isoniazid resistance detection
    Tuberculosis (TB)
    Setting
    Laboratory
  14. Nucleic acid amplification test for rifampicin resistance detection
    Nucleic acid amplification test for rifampicin resistance detection
    Tuberculosis (TB)
    Setting
    Laboratory
  15. Targeted next-generation sequencing for detection of TB drug resistance
    Targeted NGS end-to-end solutions recommended for the detection of resistance to specific anti-TB agents can be found in the targeted NGS section within the 2025 WHO operational handbook on tuberculosis. Module 3: diagnosis available at https://iris.who.int/handle/10665/382121
    Targeted next-generation sequencing for detection of TB drug resistance
    Tuberculosis (TB)
    Setting
    Laboratory
  16. Tuberculin skin test
    This is not an IVD test
    Tuberculin skin test (TST)
    Tuberculosis (TB)
    Setting
    Non-laboratory
    Assay format